Transcutaneous phrenic nerve stimulation to prevent diaphragm atrophy in ICU patients
Official title: Does Transcutaneous Phrenic Nerve Stimulation Prevent Diaphragm Atrophy?
Run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital · NCT06897774 · Data updated 2026-11-12
This study is testing if a special electrical stimulation can help prevent diaphragm weakness in ICU patients on ventilators for a long time, making it easier for them to breathe on their own again.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Bakirkoy Dr. Sadi Konuk Research and Training Hospital Government |
| Locations | 1 site (Istanbul, Bakirkoy) |
| Status | Recruiting |
| Started | January 22, 2024 |
| Main results expected | April 22, 2025 |
| Study ends | April 22, 2025 |
| Registry record updated | March 27, 2025 |
| Trial ID | NCT06897774 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are on invasive mechanical ventilation for 72 hours or more.
✕Probably not a fit
Patients under 18, those with certain medical conditions like neuromuscular diseases or severe obesity, and those requiring less than 72 hours of mechanical ventilation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the effects of transcutaneous phrenic nerve stimulation on preventing diaphragm atrophy in patients requiring invasive mechanical ventilation for over 72 hours. Participants will receive electrical stimulation through the skin to contract the diaphragm muscle, with the aim of enhancing muscle function and facilitating earlier extubation. The study will evaluate diaphragm muscle condition using ultrasonography and collect various patient data during the intervention period. Conducted at a single center, the study aims to enroll a total of 80 patients over the course of one year.
Why it matters
Potential benefit: If successful, this approach could help ICU patients recover faster by preventing diaphragm atrophy and reducing the duration of mechanical ventilation.
How similar studies have gone: While the specific approach of transcutaneous phrenic nerve stimulation is novel, similar studies have shown promise in muscle preservation during mechanical ventilation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:Patients on invasive mechanical ventilation for 72 hours or more Patients older than 18 years Exclusion Criteria: Patients under 18 years of age * Patients with less than 72 hours of mechanical ventilation * Pregnancy * Patients with a body mass index above 35kg/m² * Neuromuscular disease * Refractory epilepsy * Patients with pacemakers * ARDS * Unilateral or bilateral diaphragm paralysis * Presence of pneumothorax * Patients with large right pleural effusion * Tracheostomized patients * Patients undergoing upper abdominal surgery
Where it's running
-
Dr.SadiKonuk EAH
Istanbul, Bakirkoy, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Safiye Tuba Kaplan
- Email: sipahituba79@gmail.com
- Phone: +9
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deciphering why some patients stay a long time in the ICU using detailed clinical profiling
This study will try to identify clinical patterns in adults who stay in the ICU five days or longer to better understand persistent critical illness.
-
Delphi consensus to guide mechanical insufflation-exsufflation use in the ICU
A panel of ICU and lung specialists will use a structured survey process to agree on best practices for using mechanical insufflation-exsufflation to help airway clearance in critically ill patients.
-
Behavioral health collaborative care for family members of ICU survivors in the Post-ICU clinic pilot
This pilot tests a telehealth-based behavioral health program using the NeuroFlow app for family members of ICU survivors to try to reduce anxiety, depression, and PTSD symptoms.
-
When and how much fluid to remove in critically ill patients
This study will test which patients, timing, and rates of fluid removal (diuretics or ultrafiltration) work best for critically ill adults in the ICU who need deresuscitation.
-
Communication support for ventilated intensive care patients
This project will try an eye-tracking tablet (JIB-Tours care) to help conscious, ventilated adults in ICU who cannot speak communicate with caregivers and family.
-
Lowering sodium and chloride in diluent and maintenance IV fluids for critically ill adults
This trial will try using salt-free glucose for medication dilutions and a low-salt maintenance fluid to see if lowering sodium and chloride helps adults who need a prolonged stay in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.